National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 49821 [2012-20272]
Download as PDF
Federal Register / Vol. 77, No. 160 / Friday, August 17, 2012 / Notices
Advancing Translational Sciences, Bethesda,
MD 20892, 301–443–3367.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: September 14, 2012.
Open: 8:30 a.m. to 2:30 p.m.
Agenda: Report from the Acting Institute
Director.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Jane A. Steinberg, Ph.D.,
Executive Secretary, National Center for
Advancing Translational Sciences, Bethesda,
MD 20892, 301–443–3367.
Dated: August 13, 2012
Jennifer Spaeth
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
erowe on DSK2VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; ZEB1 OSR–D(J1) S
T32 Training and R25 Residency and Clinical
Fellows Awards Review Meeting.
Date: October 11, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National institutes of Health, DEM
II, 6707 Democracy Boulevard, Suite 941,
Bethesda, MD 20892.
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
15:13 Aug 16, 2012
Jkt 226001
Dated: August 9, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–20272 Filed 8–16–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Exercise of Authority Under the
Immigration and Nationality Act
Office of the Secretary, DHS.
Notice of determination.
AGENCY:
ACTION:
Authority: 8 U.S.C. 1182(d)(3)(B)(i).
[FR Doc. 2012–20273 Filed 8–16–12; 8:45 am]
VerDate Mar<15>2010
Democracy Boulevard, Room 959, Bethesda,
MD 20892, 301–451–3398,
hayesj@mail.nih.gov.
Following consultations with the
Secretary of State and the Attorney
General, I hereby conclude, as a matter
of discretion in accordance with the
authority granted to me by section
212(d)(3)(B)(i) of the Immigration and
Nationality Act (INA), 8 U.S.C.
1182(d)(3)(B)(i), as amended, as well as
the foreign policy and national security
interests deemed relevant in these
consultations, that paragraphs (iv)(IV),
(iv)(V), (iv)(VI), and (i)(VIII) of section
212(a)(3)(B) of the INA, 8 U.S.C.
1182(a)(3)(B), shall not apply with
respect to an alien not otherwise
covered by the automatic relief
provisions of section 691(b) of the
Consolidated Appropriations Act, 2008
or by a more specific Exercise of
Authority under section 212(d)(3)(B)(i)
of the INA, 8 U.S.C. 1182(d)(3)(B)(i),
who meets the specifications of
paragraphs (a) through (d) of this
determination.
(a) Alien Qualification: To qualify
under this determination, an alien must
have:
(1) Solicited funds or other things of
value for;
(2) Solicited any individual for
membership in;
(3) Provided material support to; or
(4) Received military-type training
from, or on behalf of, an organization
described in paragraph (b).
(b) Organization Qualification. An
organization meets the specifications of
paragraph (a) of this determination if, at
any time during the alien’s activities
discussed in paragraph (a), it was a
terrorist organization as described in
subsection 212(a)(3)(B)(vi)(III), 8 U.S.C.
1182(a)(3)(B)(vi)(III), insofar as that
organization:
(1) Is not identified in either
Executive Order 13224, as amended, or
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
49821
otherwise designated by the Secretary of
State or the Secretary of the Treasury
pursuant to the Specially Designated
Nationals List (SDNL), or in lists
established by United Nations Security
Council Committee pursuant to
Resolutions 1267 (1999) or 1988 (2011)
concerning Al-Qaida and the Taliban
and associated individuals and entities;
and
(2) Has at no time targeted U.S.
interests or persons, including planned
or attempted attacks on U.S. interests or
persons; engaged in a pattern or practice
of torture, as defined in 18 U.S.C.
2441(d)(1)(A), genocide, as described in
18 U.S.C. 1091(a), or the use of child
soldiers, as described in 18 U.S.C. 2242;
or been designated a terrorist
organization as described in subsections
212(a)(3)(B)(vi)(I) or (II) of the INA, 8
U.S.C. 1182(a)(3)(B)(vi)(I) or (II).
(c) Additional Qualifications. To meet
the requirements of this determination,
the alien must also meet the following
specifications:
(1) On or before the date of this
Exercise of Authority, was admitted as
a refugee or granted asylum, temporary
protected status, or adjustment of status
under the Nicaraguan Adjustment and
Central American Relief Act (NACARA)
or the Haitian Refugee Immigration
Fairness Act (HRIFA), or granted a
similar immigration benefit other than a
non-immigrant visa; or
(2) Is the beneficiary of an I–730
Refugee/Asylee Relative Petition filed at
any time by such an asylee or refugee.
(d) Evidentiary Requirements. An
alien must satisfy the relevant agency
authority that the alien:
(1) Is seeking a benefit or protection
under the INA and has been determined
to be otherwise eligible for the benefit
or protection;
(2) Has undergone and passed all
relevant background and security
checks;
(3) Has fully disclosed, to the best of
his or her knowledge, in all relevant
applications and interviews with U.S.
government representatives and agents,
the nature and circumstances of each
instance of solicitation, material
support, and military-type training, and
any other activity or association falling
within the scope of section 212(a)(3)(B)
of the INA, 8 U.S.C. 1182(a)(3)(B);
(4) Has not knowingly provided
material support to terrorist activities
that targeted noncombatant persons,
U.S. citizens, or U.S. interests;
(5) Has not received training that itself
poses a risk to the United States or
United States interests (e.g., training on
production or use of a weapon of mass
destruction, as defined by 18 U.S.C.
E:\FR\FM\17AUN1.SGM
17AUN1
Agencies
[Federal Register Volume 77, Number 160 (Friday, August 17, 2012)]
[Notices]
[Page 49821]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20272]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; ZEB1 OSR-D(J1) S T32 Training
and R25 Residency and Clinical Fellows Awards Review Meeting.
Date: October 11, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National institutes of Health, DEM II, 6707 Democracy
Boulevard, Suite 941, Bethesda, MD 20892.
Contact Person: John K. Hayes, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Boulevard, Room 959,
Bethesda, MD 20892, 301-451-3398, hayesj@mail.nih.gov.
Dated: August 9, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-20272 Filed 8-16-12; 8:45 am]
BILLING CODE 4140-01-P